The page is the record's research on the issuer — no analyst, no rating, no view. # Century Therapeutics, Inc. (NASDAQ: IPSC) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is Century Therapeutics, Inc., listed on NASDAQ under the ticker IPSC, with ISIN US15673T1007. Its LEI is not on the record, because no GLEIF record with the exact legal name in jurisdiction US-DE was found. Its security type is Corporate, its segment is not on the record, its sector is 2836 Biological Products, (No Diagnostic Substances), and its jurisdiction is United States, Delaware. Its listing status is listed, not halted. ## The disclosure read The record holds 112 filings in the window 2025-11-08 to 2026-11-08, across 60 filing days. The median gap between filing days is 3 days. Latency from the latest filing to the record date is 3 days. The latest filing is dated 2026-11-05 and is of type directors_dealings. Exchange peers on NASDAQ show a median cadence gap of 6.0 days, a median of 52 filings, and a median latency of 5.0 days across 4359 issuers. Sector peers in 2836 Biological Products, (No Diagnostic Substances) show a median cadence gap of 5.5 days, a median of 65.5 filings, and a median latency of 4.0 days across 176 issuers. ## Auditor The auditor of record is Ernst & Young LLP, located in Philadelphia, Pennsylvania. The record holds no auditor changes. ## Events and halts The record holds no listing, delisting or name change lines. The domicile change is not on the record, because EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, because the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted. ## Orderability The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage No research houses were found on the issuer's own investor-relations page. The count is 0. ## Open research No openly published research notes were found. The count is 0. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The issuer's years sealed are 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12. ## Sources 8 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0001850119.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NASDAQ/IPSC (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://www.sec.gov/Archives/edgar/data/1850119/000110465926026759/ipsc-20251231x10k.htm (the auditor) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/IPSC (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/IPSC · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp